Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_assertion type Assertion NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_head.
- NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_assertion wasGeneratedBy ECO_0000203 NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_provenance.
- NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_assertion wasDerivedFrom befree-20150227 NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_provenance.
- NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_assertion SIO_000772 19383237 NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_provenance.
- NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_assertion evidence source_evidence_literature NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_provenance.
- NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_assertion description "[Suppression of vascular endothelial growth factor (VEGF) expression by targeting the Bcr-Abl oncogene and protein tyrosine kinase activity in Bcr-Abl-positive leukaemia cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402038.RAj5nIsKusLnAUhRaY1Lu--_D7PyhygZyZSeig93Ps-9E130_provenance.